Similar with SCLC and NEPC, SCBC also exhibits frequent TP53/RB1 mutations, and distinct molecular subtypes characterized by unique lineage‐specific TFs, including ASCL1, NEUROD1, and POU2F3.187. Here, TP53 is linked to small cell lung carcinoma.